Combination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer.
about
TNFerade, an innovative cancer immunotherapeuticGene therapy in pancreatic cancer.Discovering the route from inflammation to pancreatic cancer.A pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancerTumor necrosis factor induces tumor promoting and anti-tumoral effects on pancreatic cancer via TNFR1.Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer.Targeting the tumor microenvironment to enhance antitumor immune responsesMesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpressionEndosonography in solid and cystic pancreatic tumorsTargeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatmentMolecular targeted approaches for treatment of pancreatic cancer.Systemic TNFα gene therapy synergizes with liposomal doxorubicine in the treatment of metastatic cancer.A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.Efficacy and safety of dendrimer nanoparticles with coexpression of tumor necrosis factor-α and herpes simplex virus thymidine kinase in gene radiotherapy of the human uveal melanoma OCM-1 cell line.Synthesis of bisethylnorspermine lipid prodrug as gene delivery vector targeting polyamine metabolism in breast cancer.Endoscopic ultrasound-guided injection therapy for hepatobiliary disease.Cytokine production suppression by culture supernatant of B16F10 cells and amelioration by Ganoderma lucidum polysaccharides in activated lymphocytes.Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes.Combining radiation therapy with interstitial radiation-inducible TNF-α expression for locoregional cancer treatment.Carcinoma pancreas
P2860
Q26776326-527B172D-0E1C-44B9-BC20-5CF923F745EFQ34302954-455D6D59-FBC4-4B2F-AC4F-9FFF6C1D8996Q34645978-430AEC28-8073-4BC5-8FAD-2D23F97CB21AQ34803980-47EA0F8C-3ED7-4351-A966-0B132ACEE2E0Q35010079-6774DEA6-012B-4C02-8A99-012635E4AA76Q35089242-2A8B8701-7DAF-4F1E-B83E-6E2A0B61A0A7Q35176307-31849505-9402-4096-8C46-5E76A18E2221Q35219548-77119D60-425F-46FE-A7C8-421B13611EACQ35954954-EE80D2A0-39BA-447C-A3AD-5A546D3BBA8BQ36150219-E42CE2CD-13F0-4909-8445-22481A0F144DQ36174910-51D54F2D-2234-4389-9755-47EE753C39CDQ36673686-8D6EF5D0-CAE2-442C-AE2C-8CD51BA1EAE3Q36870401-CFE4118D-6CE8-4D90-B258-3E01C938A122Q37225620-D762DA2C-32D1-44B3-93EA-EE1BB9E5B4A4Q37243049-2F9CB243-6CA5-4C46-B095-41676F0B50D4Q37862138-E2A6F302-B07E-4842-82D5-BF9DCACC233AQ38920354-58185B9E-839D-480A-A6E3-D801C82BE0C5Q39359422-2B190465-3FC0-4FDF-8013-BA23CBF13BAEQ39635530-B76A692D-6D47-4E8E-9358-78DA58A04F5BQ41761109-2758AFAA-0A06-4854-91AD-DECF2C417F78
P2860
Combination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Combination of human tumor nec ...... n models of pancreatic cancer.
@en
Combination of human tumor necrosis factor-alpha
@nl
type
label
Combination of human tumor nec ...... n models of pancreatic cancer.
@en
Combination of human tumor necrosis factor-alpha
@nl
prefLabel
Combination of human tumor nec ...... n models of pancreatic cancer.
@en
Combination of human tumor necrosis factor-alpha
@nl
P2093
P2860
P356
P1433
P1476
Combination of human tumor nec ...... n models of pancreatic cancer.
@en
P2093
E M O'Reilly
M O Thornton
S R Murugesan
W R Fairweather
P2860
P2888
P304
P356
10.1038/CGT.2009.32
P577
2009-05-15T00:00:00Z